{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:13:50Z","timestamp":1783480430514,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hpb.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:57:35Z","timestamp":1775260655000},"page":"877-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver transplant for combined hepatocellular-cholangiocarcinoma: United States outcomes and influence of the MMaT-3 policy"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-5450","authenticated-orcid":false,"given":"Leandro","family":"Sierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4119-0053","authenticated-orcid":false,"given":"Clive J.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria O.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Butros","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Saavedra-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5397-3082","authenticated-orcid":false,"given":"Ahmed","family":"Al-Hindawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1489-2850","authenticated-orcid":false,"given":"Eyad","family":"Abdulrazzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pojsakorn","family":"Danpanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.03.010_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/a-2730-9074","article-title":"Combined hepatocellular-cholangiocarcinoma: a clinical and molecular review","volume":"45","author":"Xu","year":"2025","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hpb.2026.03.010_bib2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","article-title":"Combined hepatocellular-cholangiocarcinoma: an update","volume":"74","author":"Beaufr\u00e8re","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2026.03.010_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020494","article-title":"Pathology of combined hepatocellular carcinoma-cholangiocarcinoma: an update","volume":"15","author":"Ro\u00dfner","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hpb.2026.03.010_bib4","first-page":"210","article-title":"Update on the diagnosis and treatment of combined hepatocellular cholangiocarcinoma","volume":"12","author":"Chu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.hpb.2026.03.010_bib5","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/cas.13656","article-title":"Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma","volume":"109","author":"Kobayashi","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hpb.2026.03.010_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.21037\/jgo-2024-1022","article-title":"Impact of postoperative chemotherapy on the prognosis of combined hepatocellular-cholangiocarcinoma: a retrospective study based on the SEER database","volume":"16","author":"Lu","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.hpb.2026.03.010_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5398-6","article-title":"Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery","volume":"19","author":"He","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2026.03.010_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7150\/ijms.50883","article-title":"The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: a propensity score matching analysis","volume":"18","author":"Tang","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.hpb.2026.03.010_bib9","doi-asserted-by":"crossref","DOI":"10.4240\/wjgs.v17.i5.105783","article-title":"Liver transplantation for combined hepatocellular cholangiocarcinoma: current evidence, selection criteria, and therapeutic controversies","volume":"17","author":"Zhou","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2026.03.010_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jamcollsurg.2020.11.017","article-title":"Multi-center analysis of liver transplantation for combined hepatocellular carcinoma-cholangiocarcinoma liver tumors","volume":"232","author":"Dageforde","year":"2021","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hpb.2026.03.010_bib11","article-title":"Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy","author":"Shaikh","year":"2025","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2026.03.010_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hpb.2015.10.001","article-title":"Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database","volume":"18","author":"Vilchez","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.03.010_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jso.23289","article-title":"Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma","volume":"107","author":"Groeschl","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hpb.2026.03.010_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133336","article-title":"Locoregional treatments in cholangiocarcinoma and combined hepatocellular cholangiocarcinoma","volume":"13","author":"Renzulli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hpb.2026.03.010_bib15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lt.25807","article-title":"Comparison of wait-list mortality between cholangiocarcinoma and hepatocellular carcinoma liver transplant candidates","volume":"26","author":"Ziogas","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2026.03.010_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110279","article-title":"Impact of hepatocellular carcinoma-related prognostic factors on combined hepatocellular cholangiocarcinoma: a surgical cohort study","volume":"51","author":"Chen","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2026.03.010_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/lt.25737","article-title":"Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in the setting of cirrhosis","volume":"26","author":"De Martin","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2026.03.010_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223878","article-title":"Patient outcomes in resected combined hepatocellular cholangiocarcinoma (cHCC-ICC) and intrahepatic cholangiocarcinoma: a single center study","volume":"16","author":"Lin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.hpb.2026.03.010_bib19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/lt.25058","article-title":"Propensity-matched analysis of patients with mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing liver transplantation: XXXX","volume":"24","author":"Lunsford","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.hpb.2026.03.010_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120574","article-title":"Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States","volume":"10","author":"Altekruse","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2026.03.010_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0000000000002970","article-title":"Differential influence of donor age depending on the indication for liver transplantation-A Collaborative Transplant Study report","volume":"104","author":"Houben","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2026.03.010_bib22","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1111\/ajt.16767","article-title":"Changes and mediators of survival disparity among Black liver transplant recipients in the United States","volume":"21","author":"Lee","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2026.03.010_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.transproceed.2022.03.009","article-title":"Predictors of long-term outcomes after liver transplantation depending on the length of cold ischemia time","volume":"54","author":"Figiel","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hpb.2026.03.010_bib24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/TP.0000000000004840","article-title":"Impact of pretransplant diabetes on outcomes after liver transplantation: an updated meta-analysis with systematic review","volume":"108","author":"Tang","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2026.03.010_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002914","article-title":"Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinoma","author":"Alsaqa","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:21:34Z","timestamp":1783477294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X26001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1365182X26001243"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.03.010","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplant for combined hepatocellular-cholangiocarcinoma: United States outcomes and influence of the MMaT-3 policy","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}